Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 6, 1998, Pages 2074-2078

  Fragoso, Maria Candida Barisson Vilares ^a   Latronico, Ana Claudia ^a   Carvalho, Filomena Marino ^a   Zerbini, Maria Claudia N ^a   Marcondes, Jose Antonio Miguel ^a   Araujo, Leila M B ^b   Lando, Valeria S ^a   Frazzatto, Eliana T ^a   Mendonca, Berenice B ^a   Villares, Sandra Mara F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CARCINOGENESIS; CHILD; FEMALE; GENE ACTIVATION; GENE MUTATION; HUMAN; HUMAN TISSUE; LEYDIG CELL TUMOR; MALE; ONCOGENE; OVARY TUMOR; PRIORITY JOURNAL;

EID: 15444339758     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.6.2074     Document Type: Article

References (25)

1. Fox H, Buckley CH, Wells M. 1995 Tumors of the female genital tract. In: Fletcher CS, ed. Diagnostic histopathology of tumor. New York: Churchill Livingstone; Chapter 13, 1:423-451.
2. Young RH, Scully RE. 1992 Endocrine tumors of ovary. Curr Top Pathol. 85:114-164.
3. Spiegel AM, Shenker A, Simonds WF, Weinstein LS. 1995 G protein dysfunction in disease. In: Weintraub, BD, ed. Molecular endocrinology: basic concepts and clinical correlations. New York: Raven Press; Chapter 20; 297-318.
4. Lyons J, Landis CA, Harsh G, et al. 1990 Two G protein oncogenes in human endocrine tumors. Science. 249:655-659.
5. Tordjman K, Stern N, Ouaknine G, et al. 1993 Activating mutations of the Gsa-gene in nonfunctioning pituitary tumors. J Clin Endocrinol Metab. 77:765-769.
6. Suarez HG, Du-Villard JA, Caillon B, Schlumberger M, Parmentier C, Monier M. 1991 gsp mutations in human thyroid tumors. Oncogene. 6:677-679.
7. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. 1991 Activating mutations of the stimulatory G protein in the McCune-Albright Syndrome. N Engl J Med. 325:1688-1695.
8. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. 1989 GTPase inhibiting mutations activate the a chain of G s and stimulate adenylyl cyclase in human pituitary tumours. Nature. 340:692-696.
9. Graziano MP, Gilman AG. 1989 Synthesis in Escherichia coli of GTPase deficient mutants of Gsα. J Biol Chem. 264:15475-15482.
10. Freissmuth M, Gilman AG. 1989 Mutations of Gsa designed to alter the reactivity of the protein with bacterial toxins: substitutions at Arg 201 result in loss of GTPase activity. J Biol Chem. 264:21907-21914.
11. Masters SB, Miller RT, Chi HT, et al. 1989 Mutations in the GTP-binding site of Gsa alter stimulation of adenylyl cyclase. J Biol Chem. 264:15467-15474.
12. Willianson EA, Daniels M, Foster S, Kelly WF, Taylor PK, Harris PE. 1994 Gαs and Gαi2 mutations in clinically non-functioning pituitary tumors. Clin Endocrinol (Oxf). 41:815-820.
13. Shen Y, Mamers P, Jobling T, Burger GH, Fuller PJ. 1996 Absence of the previously reported G protein oncogene (gip2) in ovarian granulosa cell tumors. J Clin Endocrinol Metab. 81:4159-4161.
14. 2 inhibit adenyl cyclase and attenuates receptor stimulated phospholipase A2 activity. J Biol Chem. 266:14193-14197.
15. Van Biesen T, Luttrell LM, Hawes BE, Lefkowitz RJ. 1996 Mitogenic signaling via G protein-coupfed receptors. Endocr Rev. 17:698-714.
16. Wright DK, Manos MM. 1990 Samples preparation from paraffin-embedded tissues. In: Innis MA, Gelfand DH, Sninsky JJ, White JJ, eds. PCR protocols: A guide to methods and applications. New York: Academic Press; 19:153-158.
17. Lerman LS, Fischer SG, Hurley I, Silverstein K, Lumelsky N. 1984 Sequence-determined DNA separations. Annu Rev Biophys Bioeng. 13:399-423.
18. Matzuk MM, Kumar R, Shou W, et al. 1996 Transgenic models to study the roles of inhibin and activins in reproduction oncogenesis and development. Recent Prog Horm Res. 51:123-157.
19. Watson RH, Roy WJ, Davis M, Hitchcock A, Campbel GI. 1997 Loss of heterozygosity at the α-inhibin locus on chromosome 2q is not a feature of human granulosa cell tumors. Gynecol Oncol. 65:387-390.
20. Fletcher JA, Gibas Z, Donovan K, et al. 1991 Ovarian granulosa-stromal cell tumors are characterised by trisomy 12. Am J Pathol. 138:515-520.
21. Shashi V, Golden WL, Kap-Herr C, Andersen WA, Gaffey MJ. 1994 Interphase fluorescence in situ hybridization for trisomy 12 on archival ovarian sex cord-stromal tumors. Gynecol Oncol. 55:349-354.
22. Inglese J, Freedman NJ, Koch WJ, Lefkowitz RJ. 1993 Structure and mechanism of the G protein-coupled receptor kinase. J Biol Chem. 268:23735-23738.
23. Nakano R, Kitayama S, Yamoto M, Shima K, Ooshima A. 1989 Localization of gonadotropin binding site in human ovarian neoplasm. Am J Obstet Gynecol. 161:905-910.
24. Kotlar TJ, Young RH, Albanese C, Crowley WF, Scully RE, Jameson JL. 1997 A mutation in the follicle-stimulating hormone receptor occur frequently in human ovarian sex-cord tumors. J Clin Endocrinol Metab. 82:1020-1026.
25. Marcondes JAM, Mendonca BB, Hayashida AS, Halbe W, Carvalho FM, Wajchenberg BL. 1997 A virilization Leydig cell tumor of the ovary associated with stromal hyperplasia under gonodotropin control. J Endocrinol. Invest. 20:695-689.